Why United Therapeutics Blasted 14% Higher Today

Why United Therapeutics Blasted 14% Higher Today

Specialty pharmaceutical-company United Therapeutics (NASDAQ: UTHR) was an outlier stock in the best way on Wednesday. After reporting quarterly figures showing revenue growth in all of its products, the shares closed the day over 14% higher. United Therapeutics took in $446.5 million in revenue for its Q2, which was a very healthy 23% higher year over year.